This document provides an overview of chronic kidney disease (CKD). It defines CKD as a progressive loss of kidney function over time, usually defined as a glomerular filtration rate (GFR) below 60 mL/min/1.73m2 for 3 months or more. The leading causes of CKD are diabetes and hypertension. The stages of CKD are defined based on GFR levels. Symptoms arise as GFR declines and waste builds up. Management involves controlling risk factors, treating complications, nutritional therapy, and possibly dialysis or transplantation.
Chronic kidney disease, also called chronic kidney failure, describes the gradual loss of kidney function. Your kidneys filter wastes and excess fluids from your blood, which are then excreted in your urine.
Chronic Kidney Disease, a.k.a Chronic Kidney Failure, is a vast but serious topic that requires thorough study. This presentation entails the essentials - its stages, pathogenesis, risk factors, etiology, symptoms, diagnosis, treatment and prognosis.
Chronic kidney disease, also called chronic kidney failure, describes the gradual loss of kidney function. Your kidneys filter wastes and excess fluids from your blood, which are then excreted in your urine.
Chronic Kidney Disease, a.k.a Chronic Kidney Failure, is a vast but serious topic that requires thorough study. This presentation entails the essentials - its stages, pathogenesis, risk factors, etiology, symptoms, diagnosis, treatment and prognosis.
Chronic Kidney Disease Management and caresachintutor
Chronic kidney disease (CKD) is defined as the presence of kidney damage or an estimated glomerular filtration rate (eGFR) less than 60 ml/min/1.73 mt2, persisting for 3 months or more, irrespective of the cause.
Chronic Kidney Disease Management and caresachintutor
Chronic kidney disease (CKD) is defined as the presence of kidney damage or an estimated glomerular filtration rate (eGFR) less than 60 ml/min/1.73 mt2, persisting for 3 months or more, irrespective of the cause.
Approach to chronic kidney disease abhijithV Abhijith
Contain almost all major topics associated with chronic kidney disease. Useful for medicine post graduates. I hope this presentation will help you all. Best of luck, thankyou
Chronic kidney disease (CKD) consists of a spectrum of different pathophysiologic processes associated with abnormal kidney function, and a progressive decline in glomerular filtration rate (GFR).
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
3. Introduction
• Chronic kidney disease (CKD) OR Chronic Renal Failure (CRF) involves
progressive loss of kidney function. It can develop insidiously over
many years or it may result from an episode of ARF from which client
has not covered.
• Despite of all the technological advances in life sustaining treatment
with dialysis ,patients with ESRD have a high mortality rate.
4. Definition
• Chronic or irreversible renal failure is a progressive
reduction of functioning renal tissue such that the
remaining kidney mass can no longer maintain the
body’s internal environment.
-Joyce. M . Black
• Chronic kidney disease is defined as either the presence of kidney
damage or a decreased GFR less than 60ml/min/1.73metre sq for
longer than 3 months.
-KDOQI of the National Kidney Foundation
6. Incidence
• More than 1 in 7 that is 15% of US adults or 37 million people are
estimated to have CKD.
• SEEK –India cohort study , the prevalence of CKD was 16.4%
CKD Stage 1 was 8%
Stage 2 was 3.2%
Stage 3 was 3.3%
7. Etiology and risk factors
The causes of CRF are numerous:
Diabetes – 1st leading cause
Hypertension – 2nd leading cause
11. Description GFR(ml/min/1.73 meter sq) Clinical Action Plan
Stage 1
Kidney damage with normal or
increased GFR
> Or = 90 • Diagnosis and treatment
• CVD risk reduction
• Slow progression
Stage 2
Kidney damage with mild decrease
in GFR
60-89 Estimation of progression
Stage 3 a
Moderate decrease in GFR
Stage 3b
Moderate decrease in GFR
45-59
30-44
Evaluation of treatment of
complications
More aggressive treatment of
complications
Stage 4
Severe decrease in GFR
15-29 Preparation for renal replacement
therapy(dialysis, kidney transplant)
Stage 5
Kidney failure
<15 OR Dialysis Renal replacement threrapy
17. 3. Metabolic disturbances
• Waste production accumulation
As GFR decreases , the BUN
and S.creatinine increase
.
• Altered carbohydrate metabolism:
Cellular insensitivity to normal
action of insulin
Impaired glucose metabolism
Defective carbohydrate
metabolism
33. ESTIMATION OF GFR 76 YR OLD WOMEN
(56KG)
28 YR OLD MAN
(74 KG)
Serum creatinine 1.4 mg/dl 1.4mg/dl
GFR estimated by Cockcroft Gault
Formula
30.2ml/min 82.2ml/min
GFR estimated by MDRD equation 47ml/min/1.73msq 67ml/min/1.73msq
35. 1. Medical management
a) Pharmacological therapy
a)hyperkalemia
IV glucose and insulin
IV calcium gluconate
Dialysis
b) hypertension
Target BP= less than 130/80
Weight loss
Therapeutic lifestyle
(exercise ,alcohol , smoking)
Diet recommendations : DASH diet
37. c) CKD- MBD
• Administer potassium binder
• Supplementing vit D
• Control hyperparathyroidism
• Cinacalcet, calcimimetic agent-control sec hyperparathyroidism
38. d)Anemia
• Exogenous erythropoietin (EPO)
• Dose – as ordered
• Route: IV or Subcutaneous
• Frequency: 2 or 3 times per week
• Darbopoietin Alfa – longer acting
• Administerly weekly or biweekly
• Significant increase in Hct and hb level is usually not seen for 2-
3weeks
• IV iron sucrose –For HD patients
41. Nutritional therapy
• A) Protein restriction
• PEM malnutrition
• Evaluate nutritional status:
S .albumin
Pre albumin
Ferritin
Anthropometric measurement
Recommended protein intake 1.2g/kg of IBW Per day
42. B) Water restriction
C) Sodium and potassium restriction
• Sodium restricted diets:2-4g/kg
• Dietary potassium : 2-3g
47. Nursing diagnosis
• Excess fluid volume related to impaired kidney function
• Risk for electrolyte imbalance related to impaired kidney function
resulting in hyperkalemia, hypocalcemia , hyperphosphatemia and
altered vitamin d metabolism
• Imbalanced nutrition less than body requirement related to
restricted intake of nutrients ,nausea , vomiting , anorexia and
stomatitis
50. Qn 1:Team 1
1.Modifiable risk factors for CKD include:
• a. Diabetes
• b. Hypertension
• c. History of AKI
• d. Frequent NSAID use
• e. All of the above
51. E. All of the above
Rationale: Diabetes, hypertension, history of AKI, and
frequent NSAID use can all damage the kidneys and are
risk factors for CKD
52. Qn 2: Team 2
2. World kidney day is celebrated on:
• A)May 10
• B)June 12
• C)March 10
• D)October 10
• Answer: March10
53. Qn 3: Team 3
3. GFR (ml/mt/1.73sq) rate for stage 3a CKD:
• A)39-45
• B)30-44
• C)40-59
• D)15-29
• C) 40-59
54. Qn 4: Team 4
4. The most important nutrition goal/s for patients with CKD
include:
• a. Limit Na, decrease HTN
• b. Reduce Protein
• c. Glycemic Control/Weight
• d. All of the above
55. D. All of the above
Rationale: There are several important nutrition goals for
patients with CKD, including limiting Sodium, decreasing
hypertension (if elevated), reduce protein intake, and
maintaining a proper weight.
56. Qn 5 Team 5
• A)Hypercalcemia
• B)Anemia
• C)Blood clots
• D)Hyperkalemia
• Answer: Anemia
5. A patient with CKD has a low erythropoietin
(EPO) level. The patient is at risk for?*